Skip to main content

Pfizer selects ChemAxons Markush platform

ChemAxon, a Hungarian provider of cheminformatics software for the life sciences industry, has entered into agreement with Pfizer to provide its Markush searching and structure enumeration product for deployment within Pfizer’s R&D facilities.

According to ChemAxon, its Markush structure search and enumeration prodcuct is becoming criticaly important for structure IP and patent development. Alex Drijver, CEO of ChemAxon, says: 'It is an area where ChemAxon has developed a high area of expertise and where we are moving very much into the forefront.'


Media Partners